Nfix regulates fetal-specific transcription in developing skeletal muscle.

Area of Science:

• Muscle development and regeneration
• Transcriptional regulation in cell differentiation
• Developmental biology

Background:

• Skeletal myogenesis involves distinct developmental stages with unique cell populations and gene expression.
• The transcription factor Pax7 is known to activate Nfix expression in fetal muscle.

Purpose of the Study:

• To investigate the role of the transcription factor Nuclear Factor One X (Nfix) in regulating the transition from embryonic to fetal skeletal myogenesis.
• To elucidate the molecular mechanisms by which Nfix controls gene expression during muscle development.

Main Methods:

• Analysis of gene expression patterns in embryonic and fetal muscle.
• Investigating the interaction of Nfix with other transcription factors like PKC theta and MEF2A at specific gene promoters (e.g., MCK).
• Utilizing genetic manipulation, including premature Nfix expression and muscle-specific Nfix ablation models.

Main Results:

• Nfix activates fetal-specific genes (e.g., MCK, beta-enolase) and represses embryonic genes (e.g., slow myosin).
• Nfix forms a complex with PKC theta to bind, phosphorylate, and activate MEF2A on the MCK promoter.
• Premature Nfix expression in embryonic muscle induced fetal gene expression and suppressed embryonic genes.
• Muscle-specific ablation of Nfix in fetal muscle prevented fetal gene activation and maintained embryonic gene expression.

Conclusions:

• Nfix functions as a critical transcriptional switch orchestrating the transition from embryonic to fetal skeletal myogenesis.
• Nfix plays a pivotal role in coordinating the precise temporal expression of genes essential for muscle development.
• Understanding Nfix's function provides insights into developmental processes and potential therapeutic targets for muscle disorders.